Viewing data from:

BACITRACIN

ANDA

BACITRACIN | A061699 | APOTHEKERNES LABORATORIUM A/S

1 strength0 unique patents0 unique exclusivities

API Supply Chain9 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

XELLIA PHARMACEUTICALS APSBACITRACIN STERILE USP

DMF 133411998

XELLIA PHARMACEUTICALS APSBACITRACIN USP NON-STERILE

DMF 136071998

XELLIA PHARMACEUTICALS APSBACITRACIN ZINC USP NON-STERILE

DMF 136081998

NORTH CHINA PHARMACEUTICAL HUASHENG CO LTDBACITRACIN ZINC NON-STERILE BULK DRUG SUBSTANCE

DMF 233582009

ALP PHARM BEIJING CO LTDBACITRACIN

DMF 239992010

YANCHENG YOUHUA PHARMACEUTICAL AND CHEMICAL TECHNOLOGY CO LTDBACITRACIN USP

DMF 275102013

XELLIA PHARMACEUTICALS APSBACITRACIN ZINC, STERILE

DMF 283552014

NORTH CHINA PHARMACEUTICAL HUASHENG CO LTDBACITRACIN USP

DMF 286152014

JOYANG LABORATORIESBACITRACIN

DMF 291162015

ASTRA LAKEMEDEL ABInactiveBACITRACIN

DMF 133231998

ALPHAPHARM PARTY LTDInactiveBACITRACIN

DMF 133401998

XELLIA PHARMACEUTICALS APSInactiveBACITRACIN ZINC STERILE USP

DMF 133881998

DUMEX LTDInactiveBACITRACIN

DMF 135631998

WORLD JIANGSU INDUSTRY CO LTDInactiveBACITRACIN USP, NON-STERILE DRUG SUBSTANCE

DMF 209442007

JOYANG LABORATORIESInactiveBACITRACIN USP

DMF 254042011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5,000,000 UNITS/BOT

0 patents0 exclusivities▴

POWDER;FOR RX COMPOUNDING | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.